#USA #Atlanta #A.D.A.M. #Oakstone CME #Ebix

EBIX Launches a Breakthrough Verified Medical Data Platform

EBIX recently introduced a revolutionary Verified Medical Data Platform, part of its overarching EbixONE AI initiative. This platform is designed to empower universities, hospitals, publishers, health plans, and AI firms to train AI models using two of the most reputable medical libraries worldwide: A.D.A.M. and Oakstone CME.

Meeting the Need for Quality Medical Data

With healthcare organizations rapidly adopting artificial intelligence, many patient-facing tools remain limited by data integrity and verification issues. This is critical, as AI models that lack certified medical knowledge can produce inaccurate or inconsistent advice. EBIX’s new Verified Medical Data Platform mitigates this risk. It provides partners access to thousands of medically-reviewed articles and a vast collection of anatomically and medically accurate illustrations from A.D.A.M., alongside the clinical research summaries and evidence-based guidelines from Oakstone CME.

Comprehensive Features for Enhanced AI Training

The platform offers a myriad of features, including:

• - Licensed Access: To A.D.A.M. content and Oakstone CME resources, enhancing clinical training depth.
• - Fast Integration: High-throughput connectors and APIs for efficient data ingestion into enterprise-level AI pipelines.
• - Localization Options: Customizable for global markets in multiple languages.
• - Add-on AI Tools: Optional deployment of Ebix's Health Assistant and Symptom Navigator.
• - Governance Features: Security and compliance frameworks to ensure safe operation of AI systems.

CEO Gagan Sethi emphasized the long-term investment EBIX has made in building trusted medical content libraries, saying, "We have decades of experience in delivering dependable medical content supported by diligent editorial and clinical scrutiny. As healthcare entities expedite their AI integration efforts, we are determined to furnish them with a robust data foundation that underpins the development of safe AI solutions. This initiative not only enhances our healthcare vertical but also broadens our revenue streams as the global market invests in clinically compliant AI."

Availability and Licensing

The Verified Medical Data Platform is currently available for pilot deployments globally, with a wider rollout anticipated in the first quarter of 2026. Licensing options are flexible, accommodating different content scopes and usage models. Licensing structures include annual agreements, usage-based API access, and enterprise subscriptions via an MCP server model.

Empowering Healthcare Through Innovation

Ebix Health Content and Wellness includes A.D.A.M. and Oakstone CME, providing vast educational resources designed to enhance patient engagement and health improvement. A.D.A.M. stands out as a leading patient education library that has been deployed globally, while Oakstone CME specializes in accredited education catering to the ongoing learning needs of healthcare professionals.

The initiative reflects EBIX's commitment to advancing healthcare technology and ensuring that AI applications in the healthcare sector operate on a foundation of trusted data. In doing so, they are not just developing technology but fostering a new era of care delivery that prioritizes safety and accuracy in patient interactions.

For those interested in further discussions regarding licensing or more details about the platform, EBIX encourages outreach to their operations director for comprehensive consultations.

About EBIX

Operating on a global scale, EBIX focuses on AI-driven digital marketplaces that facilitate commerce across various industries, including health and insurance. Their technology and services are designed to offer mission-critical support across highly regulated markets, leveraging APIs and digital infrastructure to optimize transactions and customer engagement. With operations in 12 countries and a reach extending to over 40 nations, EBIX remains a leader in bringing innovation to market.

For more insights into their latest offerings, you can visit their official websites.